Fatty Liver and Bariatric Surgery: Reversal, Risks, Options

What liver biopsies show after surgery, who qualifies, and why your fibrosis stage matters

Fatty Liver and Bariatric Surgery: Reversal, Risks, Options
Free
Free

Your free resource kit

1 download, made for this article.

Fatty liver and bariatric surgery are closely linked: for many people with obesity and fatty liver disease, the weight loss after a gastric sleeve or bypass clears much of the fat and inflammation from the liver, and in some cases lets early scarring heal. A randomized trial found surgery resolved liver inflammation far more often than lifestyle care alone. The one thing that changes the plan is how much scarring your liver already has, so a proper liver assessment comes first.

What is fatty liver disease, and why does weight matter?

Fatty liver disease means fat has built up inside liver cells. Its medical name changed in 2023. What used to be called NAFLD is now MASLD (metabolic dysfunction-associated steatotic liver disease), and its inflamed form, once called NASH, is now MASH. The new names were chosen by an international panel partly because the old terms felt stigmatising, and to make clear that this is a metabolic condition.1

It's very common. A large review of studies from around the world estimated that about 30% of adults have it, and the number has been rising.2

Fatty liver usually moves through stages, though not everyone goes through all of them:

  • Steatosis: extra fat in the liver, often with no symptoms.
  • MASH: the fat triggers inflammation and injures liver cells.
  • Fibrosis: the liver lays down scar tissue as it repairs that injury.
  • Cirrhosis: scarring is widespread and the liver starts to struggle.

The same forces that drive type 2 diabetes drive fatty liver: insulin resistance and excess fat stored around the organs. That's why it so often shows up alongside diabetes, high blood pressure and sleep apnea. It is a medical condition, not a verdict on how hard you've tried.

Figure 1 · Where you are on the spectrum
The four stages of fatty liver disease, and what each means for surgery Steatosis, then MASH, then fibrosis, then cirrhosis. In the first three stages weight loss surgery often helps the liver recover. With cirrhosis a liver specialist reviews first. NOT EVERYONE MOVES THROUGH EVERY STAGE Steatosisextra fat inliver cellsMASHfat plusinflammationFibrosisscar tissuebuilds upCirrhosiswidespreadscarring Surgery often helps the liver recover fat, inflammation and early scarring can improve Specialist first a hepatologist reviews before any decision
The stage decides the plan. Blood-test scores and a liver stiffness scan can estimate how much scarring you have. That's why we ask for your liver records before a surgical decision.

Can bariatric surgery reverse fatty liver?

For many people, yes, especially before cirrhosis develops. The evidence here is unusually strong because researchers can take a small sample of liver during surgery and compare it with a later sample.

"The liver is very forgiving when the weight comes off and stays off. What I ask in return is that patients keep up their liver checks and go easy on alcohol, especially after a bypass."

— Dr. Luis Pasten, Lead Bariatric Surgeon, Pompeii Surgical

  • The BRAVES randomized trial (Italy). 288 adults with biopsy-proven MASH were assigned by chance to a gastric bypass, a gastric sleeve, or lifestyle changes plus the best available medical care. After one year, the liver inflammation had resolved without the scarring getting worse in 56% of the bypass group and 57% of the sleeve group, compared with 16% of the lifestyle group.3
  • Five years of liver biopsies (France). In 180 patients with MASH who had surgery, the inflammation had resolved in 84% of those biopsied at five years. Scarring had decreased in 70% of them, and kept improving through year five rather than stopping after the first year.4
  • Long-term outcomes (US). In a study of 1,158 people with MASH and early-to-moderate scarring, those who had surgery had a 2.3% chance of a major liver event (such as cirrhosis or liver cancer) over 10 years, compared with 9.6% of similar patients who didn't. Their rate of heart attacks, strokes and heart failure was also lower.5

That last study also gives an honest reminder that surgery has risks of its own: 4 of the 650 surgery patients (0.6%) died from surgical complications in the first year.5 Your surgeon should talk through what your personal risk looks like.

The French study found one more useful thing. People whose liver inflammation persisted had lost noticeably less weight than people whose inflammation cleared.4 The surgery is a powerful start, and how you look after the result over the following years still matters.

Figure 2 · The BRAVES randomized trial
BRAVES trial: liver inflammation resolved at one year in 57% after sleeve, 56% after bypass, 16% with lifestyle care 0%25%50%75%100% Gastric sleeve57%Gastric bypass56%Lifestyle + medical care16% MASH resolved without scarring getting worse, one year after randomization
288 adults with biopsy-proven MASH were assigned by chance to a sleeve, a bypass, or lifestyle changes plus the best available medical care. Both operations worked about equally well for the liver.3

Does fatty liver change who qualifies for weight loss surgery?

It can. The 2022 joint guidelines from the American Society for Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity (IFSO) say:6

  • Surgery is recommended for anyone with a BMI of 35 or more, whether or not they have other health conditions.
  • Surgery should be considered with a BMI of 30 to 34.9 for people with metabolic disease, and MASH is one of the conditions the guideline names, especially when non-surgical treatment hasn't worked.

For someone who is 5'8", a BMI of 30 is about 197 pounds and a BMI of 35 is about 230 pounds. If you have MASH and weigh somewhere in between, you may qualify even though older rules would have said no.

Gastric sleeve or gastric bypass for fatty liver?

For the liver itself, the best evidence says both work about equally well. In the BRAVES trial the sleeve and the bypass resolved liver inflammation at almost identical rates (57% and 56%).3

So the choice usually comes down to everything else about you:

  • Reflux. A sleeve can make heartburn worse; a bypass often helps it.
  • Diabetes. People with longer-standing diabetes sometimes do better with a bypass.
  • Daily medicines. A bypass changes how some pills are absorbed.
  • Alcohol. After a bypass, alcohol hits harder and faster, which matters even more when your liver is already under strain.

Your surgeon recommends the procedure after looking at your whole history, not your liver alone.

Why do I need a liver-shrinking diet before surgery?

A fatty liver is often enlarged and heavy, and it sits right on top of the stomach. Your surgeon has to lift it aside to work, so a smaller, softer liver makes the operation safer and easier.

"I tell patients the pre-op diet is the part of the surgery they do themselves. When the liver is smaller and softer, the operation is safer, and I can see what I'm doing."

— Dr. Luis Pasten, Lead Bariatric Surgeon, Pompeii Surgical

That's the reason for the short pre-op diet, usually a low-calorie, low-carbohydrate plan in the weeks before surgery. In one imaging study of patients on a very-low-calorie diet before surgery, about 80% of the drop in liver size happened in the first two weeks.7 Your care team will tell you exactly how long your diet lasts and what to eat. We explain it in plain language in The Pre-Op Diet Explained.

Please follow it closely. It's one of the few things in the whole process that you control directly, and it really does help.

Is bariatric surgery safe if I have cirrhosis?

This is where the stage of your liver disease matters most.

"Many of my patients have a fatty liver and never knew it. Before I plan surgery I want to know how much scarring is there, because that decides whether we operate now, prepare first, or send you to a liver specialist."

— Dr. Luis Pasten, Lead Bariatric Surgeon, Pompeii Surgical

A national US study of bariatric surgery found in-hospital death rates of 0.3% for people without cirrhosis, 0.9% for people with compensated cirrhosis (the liver is scarred but still coping), and 16.3% for people with decompensated cirrhosis (the liver is failing, with problems such as fluid in the belly, internal bleeding or confusion).8 The ASMBS/IFSO guidelines say surgery can still be worth it with compensated cirrhosis in carefully selected patients, because the risk stays small and the benefits are significant.6

In practice, that means:

  • If tests suggest advanced scarring, you should see a liver specialist (hepatologist) before a surgical decision.
  • With decompensated cirrhosis, the risk is usually too high. The researchers behind that national study concluded surgery should be done only while cirrhosis is still well compensated.8
  • Many people don't know their fibrosis stage. Simple blood-test scores and a liver stiffness scan (often called a FibroScan) can estimate it.

A good surgical team will sometimes say "not yet" or "not here." That's the system working, not failing.

What about the new fatty liver medicines?

There are now two FDA-approved medicines for MASH. Resmetirom (Rezdiffra) was approved in March 2024 for adults with MASH and moderate to advanced scarring who don't have cirrhosis.9 Semaglutide (Wegovy) was approved for the same group in August 2025. In its trial, 63% of people taking it saw their liver inflammation resolve, compared with 34% on placebo.10

These are real options and good news. They're also different tools. They need to be taken long-term, insurance coverage varies, and neither has been compared head-to-head with surgery. Some people use medicine and surgery at different points in their journey. If you're weighing the two, our GLP-1 vs surgery calculator can help you compare the costs.

Traveling to Mexico for surgery with fatty liver

A little preparation makes your surgical review faster and safer. Bring or send:

  • Your most recent liver blood tests (often called LFTs, including ALT and AST) and platelet count.
  • Any ultrasound, FibroScan, CT or MRI reports that mention your liver.
  • Any fibrosis score your doctor has calculated, and the notes from any liver specialist you've seen.
  • A full list of your medicines and supplements, including any herbal products.
  • An honest account of how much alcohol you drink. It changes how your liver is assessed and treated.

At Pompeii Surgical you don't need a referral from your doctor to start, and the surgical approval review is free. If your tests show surgery isn't safe for you right now, you don't pay.

Once you're home, plan for the liver follow-up as well as the weight follow-up. Ask your doctor to repeat your liver tests during the first year, and to arrange a stiffness scan later if you had scarring before surgery.

Free downloads

Take this with you

Free. Preview the pages, then we email you the PDF (and you can download it right away).

Is weight-loss surgery right for you?

If you've been told you have fatty liver, you're not alone, and you're not out of options. The most useful next step is finding out whether surgery is realistic for your body and your liver.

You can see if you qualify in a few minutes. If you'd like a surgeon to review your history, you can start your application. To understand the procedure most of our patients choose, read about the gastric sleeve. There's no pressure and no cost to ask the question.

Key takeaway

Fatty liver disease is common, serious over time, and very responsive to large, lasting weight loss. In a randomized trial, both the sleeve and the bypass cleared liver inflammation in more than half of patients within a year, and long-term studies show scarring can improve and liver events become less likely. The stage of your liver disease decides what's safe, so get your liver properly assessed, bring your records, and keep up liver checks after surgery.

Last reviewed and updated on October 3, 2026. This article is educational and is not medical advice; talk with your own doctor about your situation.


  1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023. https://pubmed.ncbi.nlm.nih.gov/37363821/ ↩

  2. Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023. https://pubmed.ncbi.nlm.nih.gov/36626630/ ↩

  3. Verrastro O, Panunzi S, Castagneto-Gissey L, et al. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial. Lancet. 2023. https://pubmed.ncbi.nlm.nih.gov/37088093/ ↩↩

  4. Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. Gastroenterology. 2020. https://pubmed.ncbi.nlm.nih.gov/32553765/ ↩↩

  5. Aminian A, Al-Kurd A, Wilson R, et al. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. JAMA. 2021. https://pubmed.ncbi.nlm.nih.gov/34762106/ ↩↩

  6. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Obesity Surgery. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/ ↩↩

  7. Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. American Journal of Clinical Nutrition. 2006. https://pubmed.ncbi.nlm.nih.gov/16895876/ ↩

  8. Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clinical Gastroenterology and Hepatology. 2011. https://pubmed.ncbi.nlm.nih.gov/21782772/ ↩↩

  9. US Food and Drug Administration. FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease ↩

  10. Novo Nordisk A/S. Wegovy approved in the US as the first GLP-1 treatment for metabolic dysfunction-associated steatohepatitis (MASH) (Form 6-K filed with the US SEC). 2025. https://www.sec.gov/Archives/edgar/data/353278/000117184325005454/f6k_081525.htm ↩

Find out where you stand

Our short qualification check takes a few minutes. No referral needed, and the surgical review is free.

P
Written byPompeii Surgical Team

Expert contributor to Pompeii Surgical's blog, providing valuable insights on bariatric surgery and weight loss journeys.

Medically reviewed by · Oct 4, 2026Dr. Luis Pasten

Lead Bariatric Surgeon. CMCOEM-certified bariatric surgeon (2025–2030); board-certified by the Consejo Mexicano de Cirugía General. Practicing at Hospital Bellas Artes, Tijuana.